Literature DB >> 27668797

Nanomedicine: An iron age for cancer therapy.

Amy Tarangelo1, Scott J Dixon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27668797      PMCID： PMC6091215          DOI： 10.1038/nnano.2016.199

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN： 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  8 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

Authors:  Kristopher A Sarosiek; Xiaoke Chi; John A Bachman; Joshua J Sims; Joan Montero; Luv Patel; Annabelle Flanagan; David W Andrews; Peter Sorger; Anthony Letai
Journal:  Mol Cell       Date:  2013-09-26       Impact factor: 17.970

3.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

4.  Glutaminolysis and Transferrin Regulate Ferroptosis.

Authors:  Minghui Gao; Prashant Monian; Nosirudeen Quadri; Ravichandran Ramasamy; Xuejun Jiang
Journal:  Mol Cell       Date:  2015-07-09       Impact factor: 17.970

5.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

Review 6.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

Review 7.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Authors:  Dunyaporn Trachootham; Jerome Alexandre; Peng Huang
Journal:  Nat Rev Drug Discov       Date:  2009-05-29       Impact factor: 84.694

8.  Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth.

Authors:  Sung Eun Kim; Li Zhang; Kai Ma; Michelle Riegman; Feng Chen; Irina Ingold; Marcus Conrad; Melik Ziya Turker; Minghui Gao; Xuejun Jiang; Sebastien Monette; Mohan Pauliah; Mithat Gonen; Pat Zanzonico; Thomas Quinn; Ulrich Wiesner; Michelle S Bradbury; Michael Overholtzer
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213
  8 in total
  19 in total

Review 1.  Iron overload and altered iron metabolism in ovarian cancer.

Authors:  Stephanie Rockfield; Joseph Raffel; Radhe Mehta; Nabila Rehman; Meera Nanjundan
Journal:  Biol Chem       Date:  2017-08-28       Impact factor: 3.915

2.  A Ferroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Cutaneous Melanoma.

Authors:  Congcong Xu; Hao Chen
Journal:  Front Genet       Date:  2021-08-10       Impact factor: 4.599

Review 3.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

4.  Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma.

Authors:  Rui Tang; Alexander Zheleznyak; Matthew Mixdorf; Anchal Ghai; Julie Prior; Kvar C L Black; Monica Shokeen; Nathan Reed; Pratim Biswas; Samuel Achilefu
Journal:  ACS Nano       Date:  2020-04-06       Impact factor: 15.881

5.  Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.

Authors:  Behrouz Hassannia; Bartosz Wiernicki; Irina Ingold; Feng Qu; Simon Van Herck; Yulia Y Tyurina; Hülya Bayır; Behnaz A Abhari; Jose Pedro Friedmann Angeli; Sze Men Choi; Eline Meul; Karen Heyninck; Ken Declerck; Chandra Sekhar Chirumamilla; Maija Lahtela-Kakkonen; Guy Van Camp; Dmitri V Krysko; Paul G Ekert; Simone Fulda; Bruno G De Geest; Marcus Conrad; Valerian E Kagan; Wim Vanden Berghe; Peter Vandenabeele; Tom Vanden Berghe
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

6.  Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma.

Authors:  Tuo Zhang; Beibei Sun; Chenxi Zhong; Ke Xu; Zhexin Wang; Paul Hofman; Tatsuya Nagano; Antoine Legras; Daniel Breadner; Biagio Ricciuti; Duilio Divisi; Ralph A Schmid; Ren-Wang Peng; Haitang Yang; Feng Yao
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 7.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

8.  Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy.

Authors:  Yuyan Jiang; Xuhui Zhao; Jiaguo Huang; Jingchao Li; Paul Kumar Upputuri; He Sun; Xiao Han; Manojit Pramanik; Yansong Miao; Hongwei Duan; Kanyi Pu; Ruiping Zhang
Journal:  Nat Commun       Date:  2020-04-20       Impact factor: 14.919

9.  Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.

Authors:  Xuanlong Du; Yewei Zhang
Journal:  Front Genet       Date:  2020-12-18       Impact factor: 4.599

10.  A novel method for constructing continuous intrinsic surfaces of nanoparticles.

Authors:  Daniel T Allen; Christian D Lorenz
Journal:  J Mol Model       Date:  2017-07-03       Impact factor: 1.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.